Devyser announces study publication demonstrating dd-cfDNA detection in dual donor kidney transplant patients
Devyser Diagnostics AB announces today an article titled “Detection of donor-derived cell-free DNA...
Browse upcoming tradeshows we are attending, as well as virtual events or networking sessions we are running.
BeSHG 2025 Annual Meeting
Venue: Aula Magna
Ottignies-Louvain-la-Neuve, Belgium
Visit the Devyser booth or book a meeting with us.
ACMG Annual Clinical Genetics Meeting 2025
Venue: Los Angeles Convention Center
Los Angeles, USA
Visit Devyser booth 311 or book a meeting with us.
GfH Annual Conference 2025
Venue: Congress Centre Innsbruck
Innsbruck, Austria
Meet our team and learn more about our diagnostic portfolio, featuring NGS and real-time PCR solutions. Reach out for more information or book a meeting with us.
ISHLT Annual Meeting 2025
Venue: John B. Hynes Veterans Memorial Convention Center
Boston, USA
We are excited to meet you at our booth 213.
Reach out for more information or book a meeting with us.
ESHG 2025
Venue: Allianz MiCo
Milan, Italy
Come and meet us at booth 436.
Reach out for more information or book a meeting with us.
ISBT 2025
Venue: Allianz Mico
Milan, Italy
The Devyser team will be at booth B. 77. We are excited to meet you and discuss Devyser's solutions. Reach out for more information or book a meeting with us.
Register your interest for our upcoming webinars.
Webinar | Feb. 26, 2025
Devyser Thalassemia v2: The all-in-one NGS solution for alpha & beta thalassemia
Join us to learn how Devyser Thalassemia v2 can help your laboratory simplify genetic testing by integrating alpha and beta thalassemia detection—including SNV and CNV analysis, and beta modifiers—into a single, efficient assay.
Browse our webinars that are designed to provide valuable insights and knowledge on a wide range of topics
Webinar
The new guidelines on Y-chromosomal microdeletion testing
Join us for an exclusive webinar, where renowned expert Prof. Csilla Krausz will delve into the 2023 AZF testing guidelines, how they impact AZF testing, and their clinical relevance.
Webinar
Implementación del panel Devyser BRCA para la detección de SNVs y CNVs por NGS
Les invitamos a nuestro próximo webinar sobre BRCA, con Juan Torres Gregorio, especialista en Biología Molecular en CARPERMOR. Descubra cómo se implementaron las pruebas para diagnóstico de BRCA en un laboratorio acreditado por CAP en México.
Webinar
Familial Hypercholesterolemia: The importance of genetic testing
In this webinar Dr. Mafalda Bourbon talks about the role of genetic testing in familial hypercholesterolemia (FH) and preventing early cardiovascular events.
Webinar
Establishing a modern standard to provide personalized RhD prophylaxis
Professor Agneta Wikman presents how testing can help provide personalized prophylaxis for expectant mothers.
Webinar
Familial hypercholesterolemia: How an early genetic pediatric screening can guide treatment
Prof. Albert Wiegman (MD, PhD), paediatric cardiologist at Amsterdam UMC, talks about how early paediatric screening and genetic testing can guide detection and treatment of familial hypercholesterolemia (FH).
Webinar
One size fits all: Addressing hemoglobinopathy using NGS
Dr. Robert Akkers, presents the shifting distribution of hemoglobinopathy, and the need for expanded thalassemia genetic testing.
Webinar
The utility of broader CFTR genotyping in cystic fibrosis populations
Prof. Milan Macek discusses how changing demographics are driving a need for extended CFTR analysis and the value of sequencing in establishing global equitable CF diagnostics.
Webinar
Overcome the challenges of PMS2 variant calling with Devyser LynchFAP – our new NGS solution
Learn why PMS2 is the most challenging gene when it comes to variant calling in relation to hereditary colorectal cancer syndromes. Discover how Devyser LynchFAP can help you overcome this challenge.
Webinar
Spotlight on Familial Hypercholesterolemia (FH) – Uncovering the importance of genetic testing
Watch an insightful, educational session where Magdalena Daccord, Chief Executive of FH Europe, the European patient network, puts a spotlight on Familial hypercholesterolemia (FH) and the importance of genetic testing.
Webinar
NGS for thalassemia genetic testing – insights from a customer implementation journey
Watch our webinar featuring Dr. Thessalia Papasavva at the Cyprus Institute of Neurology and Genetics is performing genetic testing for thalassemia in Cyprus, both for diagnostics and as part of the national screening programs.
Webinar
Post-transplant monitoring: The future of chimerism testing
Join our webinar featuring Dr. Helena Devos, MD, Clinical Biologist and Dr. Freidel Nollet, PhD, Molecular Biologist at AZ Sint-Jan in Bruges, Belgium. Where we will talk about the implementation of an NGS solution for chimerism testing and the clinical perspectives.
News | October 29, 2024
Devyser seeks to secure FDA approval for NGS test for kidney transplant monitoringNews | October 28, 2024
Devyser Compact achieves Class III approval in ChinaDevyser Diagnostics AB announces today an article titled “Detection of donor-derived cell-free DNA...
Read More
Read More
Devyser’s novel test for detecting donor-derived cell-free DNA in blood samples from...
Read More
A better patient care is the final objective for Dr. Helena Devos and the team at Sint Jan’s...
Read More